Zoetis (NYSE:ZTS) announced a quarterly dividend on Thursday, September 12th, American Banking and Market News reports. Investors of record on Friday, November 1st will be paid a dividend of $0.065 per share on Monday, December 2nd. This represents a $0.26 annualized dividend and a dividend yield of 0.84%.
ZTS has been the subject of a number of recent research reports. Analysts at Jefferies Group cut their price target on shares of Zoetis (NYSE:ZTS) from $38.00 to $37.00 in a research note to investors on Tuesday. They now have a “buy” rating on the stock. On a related note, analysts at Argus reiterated a “buy” rating on shares of Zoetis (NYSE:ZTS) in a research note to investors on Tuesday. They now have a $38.00 price target on the stock.
Five equities research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has issued a strong buy rating to the company. The company has an average rating of “Buy” and an average target price of $36.30.
Zoetis (NYSE:ZTS) traded down 0.80% on Thursday, hitting $31.08. The stock had a trading volume of 2,881,262 shares. Zoetis has a 52-week low of $28.81 and a 52-week high of $35.42. The stock’s 50-day moving average is $30.24 and its 200-day moving average is $31.82. The company has a market cap of $15.540 billion and a price-to-earnings ratio of 37.30.
Zoetis (NYSE:ZTS) last posted its quarterly earnings results on Tuesday, August 6th. The company reported $0.36 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.36. The company had revenue of $1.11 billion for the quarter, compared to the consensus estimate of $1.13 billion. The company’s revenue for the quarter was up 1.8% on a year-over-year basis. On average, analysts predict that Zoetis will post $1.40 earnings per share for the current fiscal year.
Zoetis Inc, is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals.